Add like
Add dislike
Add to saved papers

Prospects for using a new sequential chemiluminescence strategy for monitoring the caffeine content in soft and energy drinks via the catalytic activities of different nano-metal oxides.

This article suggests a new sequential injection analysis chemiluminescence (SIA-CL) strategy for monitoring the caffeine (CAF) content in soft and energy drinks using the catalytic activities of different nano-metal oxides. The present study describes three different SIA-CL systems (luminol-ferricyanide (III) coupled with Fe2 O3 or ZnO nanoparticles (NPs), and luminol-H2 O2 coupled with CuONPs. All experimental conditions were optimized and the linear concentration ranges of pure CAF were evaluated using the calibration graphs. The selectivity of the developed SIA-CL systems was studied under the influence of various interfering species that may be present in soft or energy drinks such as sodium ions, sucrose, glucose, sodium benzoate, sodium citrate, riboflavin, niacin, citric, phosphoric and ascorbic acids. International Council for Harmonization (ICH) guidelines were obeyed for the validation of the suggested CL methods. The developed SIA-CL systems displayed linear relationships over the concentration ranges 1.0-350, 5.0-400 and 10.0-400 μg ml-1 with Fe2 O3 NPs, ZnO NPs and CuO NPs, respectively. The recorded lower limits of detection and quantification were 0.7, 2.7 and 7.8 μg ml-1 , and 1.0, 5.0 and 10.0 μg ml-1 for the previously mentioned SIA-CL systems. The results revealed high selectivity for CAF determination and were in good agreement with those obtained by other reported methods.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app